FAST Generics Act of 2019
Latest action · Feb 5, 2019 Referred to the House Committee on Energy and Commerce.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 5, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Fair Access for Safe and Timely Generics Act of 2019 or the FAST Generics Act of 2019
This bill generally prohibits the license holder of a drug or biological product approved by the Food and Drug Administration from restricting availability of the drug or product for testing by a product developer seeking to develop a drug, generic drug, or biosimilar.
Cosponsors 4
Members who signed on, in the order they did. Signatures ran from Feb 5, 2019 to May 20, 2019, with 2 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-WV | David B. McKinley | Original | Feb 5, 2019 |
| D-RI | David N. Cicilline | Original | Feb 5, 2019 |
| D-PA | Matt Cartwright | Mar 11, 2019 | |
| D-MI | Elissa Slotkin | May 20, 2019 |
Actions 2
Everything that happened, newest first.
- Feb 5, 2019Introduced in House
- Feb 5, 2019Referred to the House Committee on Energy and Commerce.
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 5, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.